Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

c-MET

Items 1-10 of 24

Page
per page
  1. AMG 337
    B6193 AMG 337
    Summary: MET inhibitor
      ≥46.3 mg/mL
  2. NPS-1034
    B6006 NPS-1034
    Summary: MET inhibitor
      Soluble in DMSO
  3. Altiratinib
    B5832 Altiratinib
     1 Citation
    Target: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2
    Summary: c-MET/TIE-2/VEGFR inhibitor
      ≥21.55 mg/mL
  4. ZM 323881 HCl
    B2302 ZM 323881 HCl
    Summary: selective VEGFR2 inhibitor
      Soluble in DMSO
  5. Golvatinib (E7050)
    B1439 Golvatinib (E7050)
    Target: VEGFR
    Summary: C-Met/VEGFR-2 inhibitor
  6. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  7. Cabozantinib malate (XL184)
    B1401 Cabozantinib malate (XL184)
    Summary: MET andVEGF receptor2 inhibitor
      ≥31.8 mg/mL
  8. NVP-BVU972
    A8489 NVP-BVU972
    Summary: C-Met inhibitor,potent and selective
      insoluble in H2O; ≥17 mg/mL
  9. INCB28060
    A8448 INCB28060
     2 Citation
    Target: c-MET
    Summary: C-Met inhibitor,ATP-competitive and novel
      insoluble in EtOH; insoluble in H2O; ≥5.15 mg/mL
  10. AMG-458
    A8361 AMG-458
    Summary: Potent c-Met inhibitor
      Soluble in DMSO

Items 1-10 of 24

Page
per page